购物车
您的购物车当前为空
CD30/TNFRSF8 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.86 kDa and the accession number is A0A2K5VW07.
别名 tumor necrosis factor receptor superfamily, member 8
CD30/TNFRSF8 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.86 kDa and the accession number is A0A2K5VW07.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 μg | ¥ 358 | 6-8日内发货 | |
| 10 μg | ¥ 582 | 6-8日内发货 | |
| 20 μg | ¥ 939 | 5日内发货 | |
| 50 μg | ¥ 1,880 | 5日内发货 | |
| 100 μg | ¥ 3,670 | 5日内发货 | |
| 200 μg | ¥ 5,580 | 5日内发货 | |
| 500 μg | ¥ 11,700 | 5日内发货 | |
| 1 mg | ¥ 23,800 | 5日内发货 |
| 产品描述 | CD30/TNFRSF8 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.86 kDa and the accession number is A0A2K5VW07. |
| 生物活性 | Immobilized Cynomolgus CD30, His Tag at 2 μg/ml (100 μl/Well) on the plate. Dose response curve for Anti-CD30 Antibody, hFc Tag with the EC50 of 6.0 ng/ml determined by ELISA (QC Test). |
| 研究背景 | CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 protein is expressed by activated, but not resting, T and B cells. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication. As a regulator of apoptosis, CD30 protein induces cell death or proliferation, depending on the cell type, and has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. CD30 protein expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs), and CD30 is also linked to leukocytes in patients with chronic inflammatory diseases, including lupus erythematosus, asthma, rheumatoid arthritis and atopic dermatitis (AD).Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| 种属 | Cynomolgus |
| 表达系统 | HEK293 Cells |
| 标签 | C-His |
| 蛋白编号 | A0A2K5VW07 |
| 蛋白构建 | Ala27-Pro394 |
| 蛋白纯度 | > 95% as determined by Bis-Tris PAGE;
> 95% as determined by HPLC |
| 蛋白性状 | Lyophilized powder |
| 缓冲液 | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| 复溶方法 | Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
| 别名 | tumor necrosis factor receptor superfamily, member 8 |
| 内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
| 分子量 | 39.86 kDa (predicted); 75-105 kDa (reducing condition, due to glycosylation) |
| 运输方式 | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多